Article Details

Blueprint Medicines (NASDAQ:BPMC) Price Target Raised to $132.00

Retrieved on: 2020-12-01 07:12:16

Tags for this article:

Click the tags to see associated articles and topics

Blueprint Medicines (NASDAQ:BPMC) Price Target Raised to $132.00. View article details on hiswai:

Excerpt

<b>AQR Capital Management</b> LLC now owns 26,793 shares of the biotechnology company's stock valued at $2,090,000 after buying an additional 1,143 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up